SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-24-000002
Filing Date
2024-01-05
Accepted
2024-01-05 16:03:27
Documents
14
Period of Report
2024-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20240105.htm   iXBRL 8-K 47611
2 EX-99.1 abbv-20231231nonxgaapxex991.htm EX-99.1 17087
  Complete submission text file 0001551152-24-000002.txt   292797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20240105.xsd EX-101.SCH 4295
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20240105_def.xml EX-101.DEF 20637
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20240105_lab.xml EX-101.LAB 42434
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20240105_pre.xml EX-101.PRE 21418
8 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20240105_htm.xml XML 10287
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 24516198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)